9 completed, 2 unknown. 11 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 11 | Completed 9, Unknown 2 |
Follow Non-Hodgkin's Lymphoma: new trials by email Literature Review of Non-Hodgkin's Lymphoma trials Research Report on Non-Hodgkin's Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ultrafast Truxima Infusion in Non-Hodgkin's Lymphoma: Txagorapid Study RiTUXimab Injection [Truxima] - Non-Hodgkin's Lymphoma | Phase 4 | Unknown | Laida Cuevas Palomares | 48 | 2021-09-28 | 2022-03-31 |
| Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma temsirolimus - Non-Hodgkin's Lymphoma | Phase 4 | Completed | Pfizer | 101 | 2011-03-01 | 2019-05-20 |
| Evaluation of Approved Weight-Based Dose Compared to Fixed Dose of Plerixafor in Patients With Non-Hodgkin's Lymphoma (NHL) Weighing Less Than 70 Kilograms Granulocyte-colony stimulating factor (G-CSF), Fixed Dose Plerixafor, Weight-Based Plerixafor - Non-Hodgkin's Lymphoma | Phase 4 | Completed | Genzyme, a Sanofi Company | 61 | 2010-10-01 | 2014-02-25 |
| Doxorubicin Pharmacokinetics and Response in Non Hodgkin's Lymphoma Doxorubicin - Non-Hodgkin's Lymphoma | Phase 4 | Completed | Meir Medical Center | 18 | 2009-09-01 | 2013-07-01 |
| Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in Adults Rituximab - Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma | Phase 4 | Unknown | University of Bologna | 25 | 2006-12-01 | 2009-09-15 |
| MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma. rituximab [MabThera/Rituxan] - Non-Hodgkin's Lymphoma | Phase 4 | Completed | Hoffmann-La Roche | 545 | 2006-09-04 | 2017-08-14 |
| An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL) Chemotherapy, Immunochemotherapy, Pegfilgrastim - Non-Hodgkin's Lymphoma | Phase 4 | Completed | Hoffmann-La Roche | 53 | 2006-06-01 | 2016-11-21 |
| PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation Kepivance (Palifermin) - Non-Hodgkin's Lymphoma, Multiple Myeloma | Phase 4 | Completed | Swedish Orphan Biovitrum | 145 | 2006-04-01 | 2014-11-03 |
| Prevention of CHOP-induced Chronic Cardiotoxicity Valsartan - Non-Hodgkin's Lymphoma | Phase 4 | Completed | Osaka City University | 150 | 2004-05-01 | 2012-05-08 |
| Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma rituximab - Non-Hodgkin's Lymphoma | Phase 4 | Completed | Biogen | 168 | 2003-10-01 | 2009-10-20 |
| A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer Neulasta (pegfilgrastim) - Neutropenia, Breast Cancer | Phase 4 | Completed | Amgen | 852 | 2002-06-01 | 2010-10-08 |
Lymphoma, Non-Hodgkin (11) · Breast Neoplasms (1) · Cardiomyopathies (1) · Lung Neoplasms (1) · Lymphoma, Mantle-Cell (1) · Multiple Myeloma (1) · Neutropenia (1) · Ovarian Neoplasms (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Stomatitis (1)
Hemic and Lymphatic Diseases (11) · Immune System Diseases (11) · Immunoproliferative Disorders (11) · Lymphatic Diseases (11) · Lymphoma (11) · Lymphoproliferative Disorders (11) · Neoplasms (11) · Neoplasms by Histologic Type (11) · Hematologic Diseases (3) · Cardiovascular Diseases (2) · Adnexal Diseases (1) · Agranulocytosis (1) · Blood Protein Disorders (1) · Breast Diseases (1) · Cytopenia (1)
Rituximab (4) · Doxorubicin (2) · Granulocyte Colony-Stimulating Factor (2) · pegfilgrastim (2) · Cyclophosphamide (1) · Cytarabine (1) · Dexamethasone (1) · Drug Therapy (1) · Fibroblast Growth Factor 7 (1) · Filgrastim (1) · Ifosfamide (1) · Prednisone (1) · Valsartan (1) · Vincristine (1) · plerixafor (1)
Hoffmann-La Roche (2) · Amgen (1) · Biogen (1) · Genzyme, a Sanofi Company (1) · Laida Cuevas Palomares (1) · Meir Medical Center (1) · Osaka City University (1) · Pfizer (1) · Swedish Orphan Biovitrum (1) · University of Bologna (1)
Germany (3) · Italy (3) · Romania (3) · Russia (3) · United States (3) · Australia (2) · Colombia (2) · Czechia (2) · France (2) · Israel (2) · Mexico (2) · South Korea (2) · Spain (2) · Sweden (2) · Turkey (Türkiye) (2)
Avishay Elis, MD (1) · Giovanni Martinelli, MD (1) · Hirohisa Nakamae, MD, PhD (1) · Laida Cuevas Palomares (1) · Masayuki Hino, MD, PhD (1)
PMID 18165618, PMID 20118030, PMID 24824768
2009 (1), 2019 (1)